Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

KIORA PHARMACEUTICALS INC Director's Dealing 2017

Nov 15, 2017

35256_dirs_2017-11-15_1d0a119e-157f-45d9-ab7d-8123046a1cd0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: EYEGATE PHARMACEUTICALS INC (EYEG)
CIK: 0001372514
Period of Report: 2017-11-01

Reporting Person: Garanzini Michael (Chief Commercial Officer)